Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures

Annals of Neurology

Volumn 40, Issue 5, 1996, Pages 750-758

  McDonald, John W ^a   Goldberg, Mark P ^a   Gwag, Byoung J ^a   Chi, Shu Ing ^a   Choi, Dennis W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYCLOHEXIMIDE; CYCLOSPORIN; DEOXYURIDINE; DNA FRAGMENT; GLUTAMATE RECEPTOR; SOMATOMEDIN;

APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DEATH; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW;

EID: 0029804767     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400511     Document Type: Review

References (57)

1. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-1738
2. Keown PA. Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity. Drugs 1990;40:315-325
3. Thompson AW, Neild GH. Cyclosporine: use outside transplantation. BMJ 1991;302:4-5
4. Berden JHM, Hoitsuma AJ, Merx JL, Keyser A. Severe central-nervous-system toxicity associated with cyclosporin. Lancet 1985;1:219-220
5. de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of Cyclosporine and cholesterol. N Engl J Med 1987;317:861-866
6. Walker RW, Brochstein JA. Neurologic complications of immunosuppressive agents. Neurol Clin 1988;6:261-278
7. Atkinson K, Briggs J, Darveniza P, et al. Cyclosporine-associated central nervous system toxicity after allogenic hone marrow transplantation. N Engl J Med 1984;310:527
8. Beaman M, Parvin S, Veitch PS, Walls J. Convulsions associated with cyclosporin A in renal transplant recipients. BMJ 1985;290:139-140
9. Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987;37:1072-1076
10. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401
11. Patchell RA. Neurologic complications of organ transplant. Ann Neurol 1994;36:688-703
12. Wijdicks EFM, Wiesner RH, Krom RAF. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995;45:1962-1964
13. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporine neurotoxicity and hypomagnesemia. Lancet 1984;2:1116-1120
14. Ghalie R, Fitzsimmons WE, Bennett D, Kaizer H. Cortical blindness: a rare complication of cyclosporin therapy. Bone Marrow Transplant 1990;6:147-149
15. Hughes RL. Cyclosporine-related cerebral nervous system toxicity in cardiac transplantation. N Engl J Med 1990;323:420-421
16. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR 1991; 12:651-659
17. Jansen O, Kreiger D, Hermann S, et al. Hyperintense cortex in proton-density weighted images: a new MRI sign in cyclosporin-A-induced encephalopathy after liver transplantation. Neurology 1995;45:899S
18. Monteiro L, Almeida-Pinto J, Rocha N, et al. Case report: cyclosporin A-induced neurotoxicity. Br J Radiol 1993;66: 271-272
19. Lopez OL, Martinez AJ, Torre-Cisneros J. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK-506. Transplant Proc 1991;23:3181-3182
20. Boon AP, Adams DH, Carey MP, et al. Cyclosporin-associated cerebral lesions in liver transplantation. Lancet 1988;1:1457
21. Tanaka T, Takeda M, Nigawa H, et al. Phosphorylated neurofilament accumulation in neuronal perikarya by cyclosporin A injection in rat brain. Methods Find Exp Clin Pharmacol 1993;15:77-87
22. Famiglio L, Racusen L, Fivush B, et al. CNS toxicity of cyclosporine in a rat model. Transplant 1989;48:316-321
23. Stoltenburg-Didinger G, Boegner F. Glia toxicity in dissociated cell cultures induced by cyclosporine. Neurotoxicology 1992; 13:179-184
24. McDonald JW, Goldberg MP, Choi DW, Chi S-I. Cyclosporin-A induces apoptosis in cultured cortical neurons. Ann Neurol 1995;38:307
25. McDonald JW, Gwag BJ, Goldberg MP, et al. Cyclosporin-A and okadaic acid induce apoptosis in cultured cortical neurons. Soc Neurosci Abstr 1995;21:751
26. Chi S-I, Sklow B, Goldberg MP, Choi DW. Cyclosporin exposure is cytotoxic to cultured cortical neurons. Soc Neurosci Abstr 1993;19:1317
27. Rose K, Goldberg MP, Choi DW. Cytotoxicity in murine cortical cell culture. In: Tyson CA, Frazier JM, eds. In vitro biological methods, methods in toxicology. San Diego, CA: Academic, 1992:46-60
28. Koh J, Choi DW. Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987;20:83-90
29. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336
30. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via a specific labeling of DNA nuclear fragmentation. J Cell Biol 1992;119:493-501
31. Kerr JFK, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomena with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257
32. Johnson EM Jr, Deckwerth TL. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 1993; 16:31-46
33. Martin DP, Schmidt RE, diStefano PS, et al. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988; 106:829-844
34. Kharlamov E, Cagnoli CM, Atabay C, et al. Opposite effect of protein synthesis inhibitors on potassium deficiency-induced apoptotic cell death in immature and mature neuronal cultures. J Neurochem 1995;65:1395-1398
35. Deierhoi MH, Kalayoglu M, Sollinger HW, Belzer FO. Cyclosporine neurotoxicity in liver transplant recipients: report of three cases. Transplant Proc 1988;20:116-118
36. Goto S, Matsukado Y, Mihara Y, et al. The distribution of calcineurin in rat brain by light and electron microscopy immunohistochemistry and enzyme-immunoassay. Brain Res 1986;397:161-172
37. Steiner JP, Dawson TM, Fotuhi M, et al. High brain density of the immunophilin FKBP colocalized with calcineurin. Nature 1992;358:584-587
38. Neild GH, Rocchi G, Imberti L, et al. Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits. Transplant Proc 1983;15(suppl 1):2398-2400
39. Boogaerts MA, Tricot G, Westelinck K, Verwilghen RL. Cyclosporin-syndrome post bone marrow transplantation: interference with vascular prostacyclin production. Blood 1984; 64(suppl 1):210a
40. de Groen PC, Aksamit AJ, Rakela J, Krom RAF. Cyclosporine-associated central nervous system toxicity. N Engl J Med 1988; 318:789
41. Csernansky CA, Canzoniero LM, Sensi SL, et al. Delayed application of aurintricarboxylic acid reduces glutamate-induced cortical neuronal injury. J Neurosci Res 1994;38:101-108
42. Koh J-Y, Gwag BJ, Lobner D, Choi DW. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 1995; 268:573-575
43. Borner MM, Myers CE, Sartor O, et al. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 1995;55:2122-2128
44. Chung E, Dvorozniak MT, Van Woert MH, Li HC. Regional distribution of calcium/calmodulin-dependent phosphatase activity of calcineurin in rat brain. Res Commun Chem Pathol Pharmacol 1989;64:357-371
45. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 1988; 255:357-360
46. Strzelecki T, Kumar S, Khauli R, Menon M. Impairment by cyclosporine of membrane-mediated functions in kidney mitochondria. Kidney Int 1988;34:234-240
47. Henke W, Jung K. Comparison of the effects of the immunosuppressive agents FK-506 and cyclosporin A on rat kidney mitochondria. Biochem Pharmacol 1993;46:829-832
48. Harris DT, Kozumbo WJ, Cerutti PA, Cerottini JC. Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes. Cell Immunol 1987;109: 104-114
49. Shiga Y, Onodera H, Matsuo Y, Kogure K. Cyclosporin-A protects against ischemia-reperfusion injury in the brain. Brain Res 1992;595:145-148
50. Dawson TM, Steiner JP, Dawson VL, et al. Immunosuppressant FK506 enhances phosphorylation of nitric acid synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993;90:9808-9812
51. Ogawa N, Tanaka K-i, Kondo Y, et al. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci Lett 1993; 152:173-176
52. Moia LJMP, Matsui H, de Barros GAM, et al. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK-506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Brain Res 1994;648:337-341
53. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK-506 in focal cerebral ischaemia. Nature 1994;371:336-339
54. Shi YF, Sahai BM, Green DR. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 1989;339:625-626
55. 2+ and oxidative stress. FEBS 1992;304:192-194
56. Griffiths EJ, Halestrap AR. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 1993;25:1461-1469
57. Koh JY, Wie MB, Gwag BJ, et al. Staurosporine induced neuronal apoptosis. Exp Neurol 1995:135:153-159